期刊文献+

流感病毒载体的应用研究进展

Progress on the application of influenza virus vectors
原文传递
导出
摘要 流感是一种危害极大的传染病,而经流感病毒改造而来的流感病毒载体却在疾病治疗和预防上有着美好的应用前景。流感病毒载体具有独特的优势,利用反向遗传技术改造流感病毒作为载体已经多有报道,此文综述了流感病毒载体应用的相关进展。 Influenza is a harmful infectious disease. However, influenza virus vectors derived from influenza virus are hopeful to be used in the prevention and treatment for different diseases. There are several reports on influenza virus vectors constructed by reverse genetic system. In this review, the progress on the application of influenza virus vectors is discussed.
作者 李颖 郭潮潭
出处 《国际流行病学传染病学杂志》 CAS 2009年第4期268-270,共3页 International Journal of Epidemiology and Infectious Disease
基金 国家自然科学基金(30872163)
关键词 流感病毒 载体 应用 Influenza virus Vectors Application
  • 相关文献

参考文献13

  • 1Bergmann M, Romirer I, Sachet M, et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res, 2001, 61(22): 8188-8193.
  • 2Kittel C, Ferko B, Kurz M, et al. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol, 2005, 79(16): 10672-10677.
  • 3Restifo NP, Surman DR, Zheng H, et al. Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer. Virology, 1998, 249(1 ) : 89-97.
  • 4Strobel I, Krumbholz M, Menke A, et al. Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector. Hum Gene Ther, 2000, 11(16) : 2207- 2218.
  • 5Efferson CL, Schickli J, Ko BK, et al. Activation of tumor antigenspecific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene. J Virol, 2003, 77 (13) : 7411-7424.
  • 6Ferko B, Katinger D, Grassauer A, et al. Chimeric influenza replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodellcieney virus type 1 in the genital tract. J Infect Dis, 1998, 178(5) : 1359-1368.
  • 7Ferko B, Stasakova J, Sereinig S, et al. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucesal immune responses in mice. J Virol, 2001, 75(19): 8899-8908.
  • 8Sereinig S, Stukova M, Zabolotnyh N, et al. Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4^+ Th1 immune response and protect animals against tuberculosis challenge. Clin Vaccine Immunol, 2006, 13(8): 898- 904.
  • 9Staczek J, Gilleland HE Jr, Gilhland LB, et al. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of Chronic pulmonary infection. Infect Immun, 1998, 66(8): 3990-3994.
  • 10Hale BG, Randall RE, Ortin J, et al. The multiftmctional NSI protein of influenza A viruses. J Gen Virol, 2008, 89(Pt 10) : 2359- 2376.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部